Position in TAK
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,909,078
+$430,710 QoQ
Shares Held
103,082
+8.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Derivatives in TAK
reported options exposure · as of Dec 31, 2021CallValue
$0
CallShares
0
PutValue
$136
PutShares
10
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026HighTower Advisors, LLC holds $76,791,783 across 32 Drug Manufacturers - Specialty & Generic names. TAK ranks #5 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
419,904 | $49,636,851 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
224,067 | $6,748,898 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
4,894 | $2,902,044 | |
| 4 | HLN |
Haleon plc
|
192,177 | $1,923,691 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
103,082 | $1,909,078 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
11,198 | $1,475,224 | |
| 7 | VTRS |
Viatris Inc
|
108,052 | $1,459,782 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
93,386 | $1,160,787 |
All Filings in TAK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,909,078 | 103,082 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,478,368 | 94,828 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,447,046 | 98,842 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,489,184 | 96,325 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,304,768 | 87,745 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,647,572 | 124,439 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,743,187 | 122,587 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $529,685 | 40,934 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,292,561 | 93,057 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,202,532 | 84,270 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,295,148 | 83,720 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,120,075 | 71,297 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $538,006 | 32,646 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $412,495 | 26,442 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $303,848 | 23,427 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $339,009 | 24,146 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $405,628 | 28,326 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $136 | 10 | Put | Sole | 2022-02-10 | |
| 2021-12-31 | $359,191 | 26,353 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $517,820 | 31,613 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $542,329 | 32,224 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $484,949 | 26,558 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $416,124 | 22,864 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $438,828 | 24,598 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $425,102 | 23,709 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $288,647 | 19,015 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||